| Name | Title | Contact Details |
|---|
Nuvectra™ is a neuromodulation company committed to helping physicians improve the lives of people with chronic conditions through our medical devices. At Nuvectra, we focus not only on what our devices do, but also on reducing their complexity for clinicians and patients. We are committed to developing products with intelligent innovations and technologies that provide improved outcomes and long-term solutions for our customers. The Algovita® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder and deep brain stimulation (DBS) for the treatment of Parkinson`s Disease. NeuroNexus, a subsidiary owned by Nuvectra, designs, manufactures, and markets leading-edge neural-interface technologies for the neuroscience clinical research market.
Dynacare Laboratories is a Milwaukee, WI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bostwick Labs is a Tempe, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Behavioral Health Sciences Institute is a Portland, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyse components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research. We are headquartered in Cambridge UK. Our eight additional sales, production, and distribution offices are located in Asia, UK, and the USA. Our mission is to help scientists to discover more. Our vision is to be the brand most recommended by life science researchers. We recognise the importance of providing clear and timely information to our existing and potential shareholders and hope that you will find this website helpful on informing your investment decisions.